Exer Labs, Inc.

Exer Labs develops an FDA-registered Class II medical device software platform that delivers AI-powered motion analysis and clinical decision support for musculoskeletal and movement disorders. The platform captures objective movement data via smartphone or tablet cameras (no wearables required) in clinic and home settings, applying proprietary neural networks to generate real-time insights on gait, joint mobility, hand/wrist function, and functional movement patterns. The system is HIPAA-compliant and integrates with existing EHR workflows via barcode scanning and APIs. Primary clinical applications include orthopedics (major joints, hand, wrist), neurology (Parkinson's, digital movement evaluation), physical medicine and rehabilitation (personalized treatment planning), senior living (fall risk detection and prevention), and primary care (early intervention and objective outcome tracking). The platform features in-clinic capture apps, at-home patient monitoring via mobile app, real-time clinician dashboards, automated billing reports, and standardized outcome measures. Exer's AI is wholly proprietary and internally trained. Clinical validation includes collaborations with Mayo Clinic (hand and wrist disorders), Wake Orthopedics, and Legacy Healthcare (senior living), with demonstrated accuracy compared to traditional goniometry. The solution addresses provider workflow integration, remote monitoring capabilities, and cost optimization through reduction of unnecessary diagnostic testing and improved care coordination across inpatient, outpatient, and home-based care settings.